Clinical Trials Logo

Clinical Trial Summary

Based on the known efficacy of ablative single dose SBRT and VMAT technique in various solid tumors, investigators have designed this study to assess feasibility of SBRT in selected patients with spine metastases.


Clinical Trial Description

This is a prospective, phase 2 study. The main objectives are to assess acute and late side effects of single fraction SBRT for selected patients with vertebral metastases and to study the local control of disease in treated sites. The schedule will be 1 fraction of 18 Gy delivered in one day with Volumetric Modulated Arc Therapy (VMAT) and Flattening filter-free (FFF) beams. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02616887
Study type Observational
Source Istituto Clinico Humanitas
Contact
Status Terminated
Phase
Start date November 5, 2015
Completion date February 8, 2022

See also
  Status Clinical Trial Phase
Completed NCT01347307 - Stereotactic Body Radiotherapy for Spine Tumors N/A
Completed NCT02464761 - Photodynamic Therapy for the Treatment of Vertebral Metastases Phase 1